期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基质金属蛋白酶诱导因子和白三烯B_4在急性冠状动脉综合征中表达 被引量：8

Expression of extracellularmatrix metalloproteinase inducer and leukotriene B_4 in patient with acute coronary syndrome
原文传递
导出
摘要 目的:研究基质金属蛋白酶诱导因子(EMMPRIN)及白三烯B4(LTB4)在急性冠状动脉综合征中表达。方法:设立稳定型心绞痛组(SAP组)、不稳定型心绞痛组(UAP组)、急性心肌梗死组(AMI组)及对照组(CON组),以流式细胞计数法测定患者外周静脉血单核细胞表面EMMPRIN表达,ELISA法检测其血清LTB4水平。结果:EMMPRIN在UAP组显著高于CON组、SAP组、AMI组,在UAP<1周亚组表达明显。LTB4在AMI组显著高于CON、SAP和UAP组,其AMI<24h亚组增高显著。结论:UAP患者外周血单核细胞表面EMMPRIN表达增高,其出现高峰为胸痛1周内;AMI患者血清中LTB4表达上调,高峰为胸痛24h之内。 Objective：To study the expression of extracellularmatrix metalloproteinase inducer（EMMPRIN） and leukotriene B4（LTB4） in patient with acute coronary syndrome（ACS）.Method：There were four groups in this study,including SAP,UAP,AMI,and CON group.The expression of EMMPRIN on peripheral blood mononuclear cells were determined by flow cytometry,while LTB4 level in serum was measured by ELISA.Result：The expression of EMMPRIN in UAP patients was significantly higher than that in CON,SAP and AMI groups,especially in 1 week.The level of LTB4 in AMI group was higher than the other three groups,especially in 24 hours.Conclusion：EMMPRIN on peripheral blood mononuclear cells increased significantly in UAP patients with the peak in 1 week.Serum LTB4 increased in AMI patients with the peak in 24 hours.
作者 许莎莎 黄洁 江建军 王教辰 米亚非 刘志国 卢先本 薛迎生 葛卫力 王琳 陈保国 朱敏 黄维清 唐礼江
机构地区 温州医学院附属台州医院心内科 温州医学院附属台州医院病理科 温州医学院附属台州医院中心实验室 山东省青岛市市立医院东院病理科
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第3期220-222,共3页 Journal of Clinical Cardiology
基金 浙江省科技厅基金资助(No:2006c33019)
关键词 急性冠状动脉综合征 细胞外基质金属蛋白酶诱导剂 白三烯B4 acute coronary syndrome extracellularmatrix metalloproteinase inducer leukotriene B4
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献15

  • 1BACK M.Leukotriene signaling in atherosclerosis and ischemia[J].Cardiovasc Drugs Ther,2009,23:41-48.
  • 2TARDIF J C,L'ALLIER P L,IBRAHIM R,et al.Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome[J].Circ Cardiovasc Imaging,2010,3:298-307.
  • 3ZHOU G,GE S,LIU D,et al.Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway[J].Cardiology,2010,115:221-228.
  • 4LEE S J,KIM C E,YUN M R,et al.4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK[J].Toxicol Appl Pharmacol,2010,242:191-198.
  • 5HLAWATY H,JACOB M P,LOUEDEC L,et al.Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis[J].Arterioscler Thromb Vasc Biol,2009,29:518-524.
  • 6AHLUWALIA N,LIN A Y,TAGER A M,et al.Inhibited aortic aneurysm formation in BLT1-deficient mice[J].J Immunol,2007,179:691-697.
  • 7NEWBY A C.Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture[J].Physiol Rev,2005,85:1-31.
  • 8SCHMIDT R,BULTMANN A,UNGERER M,et al.Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells:implications in acute myocardial infarction[J].Circulation,2006,113:834-841.
  • 9YUE H H,LENG N,WU Z B,et al.Expression of CD147 on phorbol-12-myristate-13-acetate (PMA)-treated U937 cells differentiating into foam cells[J].Arch Biochem Biophys,2009,485:30-34.
  • 10CHEN X F,WANG J A,HOU J,et al.Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin Ⅱ in vitro[J].Clin Sci (Lond),2009,116(11):819-826.

二级参考文献10

  • 1LIBBY P. Inflammation in atherosclerosis[J]. Nature, 2002,420(6917) :868--874.
  • 2FRIEDRICH E B, TAGER A M, EMERSON L, et al. Mechanisms of leukotriene B4-triggered monocyte adhesion[J]. Arterioscler Thromb Vasc Biol, 2003,23:1761--1766.
  • 3HUANG L, ZHAO A, WONG F, et al. Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes[J]. Arterioscler Thromb Vasc Biol, 2004,24 : 1783 -- 1788.
  • 4CIPOLLONE F, MEZZETTI A, FAZIA M L, et al.Association between 5-lipoxygenase expression and plaque instability in humans [J]. Arterioscler Thromb Vasc Biol, 2005, 25:1665--1670.
  • 5ZHAO L, MOOS M P, GRABNER R, et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm [J]. Nat Med, 2004, 10:966--973.
  • 6FUKUDA D, SHIMADA K, TANAKA A, et al.Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris[J]. Am J Cardiol, 2006,97:175--180.
  • 7DEVARAJ S, O'KEEFE G, JIALAL I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker[J].J Clin Endocrinol Metab, 2005,90:4549--4554.
  • 8NOMOTO K, OGUCHI S, WATANABE I, et al.Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9and soluble vascular-cell adhesion molecule-1[J]. J Cardiol, 2003,42:201--206.
  • 9BACK M, BUD X, BRANSTROM R, et al. Leukotriene 134 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia[J]. Proc Natl Acad Sci U S A, 2005,102:17501--17506.
  • 10HAKONARSON H, THORVALDSSON S, HEL-GADOTTIR A, et al. Effects of a 5-lipoxygenase -activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial[J]. JAMA, 2005, 293:2245--2256.

共引文献7

同被引文献78

引证文献8

二级引证文献51

临床心血管病杂志
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部